All Articles

Real-world analysis of mutations in non–small-cell lung cancer showed similar frequencies of common KRAS and EGFR variants in Black and White Americans, but higher EGFR G719S variant was seen in Black Americans.

When clinicians and patients rely on different terminology for the term “cure” in cancer treatment, it can lead to patient dissatisfaction and confusion.

Next-generation sequencing at initial workup of the patient with advanced non–small-cell lung cancer can shorten time between diagnosis and treatment and may improve survival.

Recent study found that the use of sotorasib after anti–PD-L1 therapy in patients with NSCLC increased the chance of severe adverse events and liver toxicity.

Patients with non–small-cell lung cancer with a history of prior radiotherapy before immune checkpoint inhibitor treatment are at increased risk for developing severe pneumonitis.

At JONS, we value the art of practicing medicine. We also value Art as Medicine to lift the human spirit. To honor these values, we have established an Artist in Residency program to showcase the works of art by artists touched by cancer.

The Navigating Iron Deficiency Anemia: My IV Iron Treatment Guide patient resource aims to empower patients and/or caregivers to actively engage in the discussion of iron deficiency anemia (IDA) and the intravenous (IV) iron treatment decision-making process.

The CATCH for September 2022 is awarded to Stephanie Hoopes, BSN, RN, OCN, ONN-CG, a survivorship nurse navigator at Prisma Health Cancer Institute in Greenville, SC.

In the United States, the second most commonly diagnosed cancer in both men and women is lung cancer, including both non–small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC).